Citations

Institution: Mayo Clinic Clear

Showing 10 of 108162 citations.

Patient and Procedural Factors that Influence Anesthetized, Nonoperative Time in Spine Surgery
Puffer, Ross C. , Mallory, Grant W., Burrows, Anthony M. , Curry, Timothy B. , Clarke, Michelle J.

Global Spine Journal | September 29, 2015 | Volume: 6 | Issue: 5 | Pages: 447-451

10.1055/s-0035-1564808 | PMID 27433428 Get It

Study Design Retrospective study. Objective Efficient use of operating room time is important, as delays during induction or recovery increase time not spent operating while in the operating room. We identified factors that increase anesthetized, nonoperative time by utilizing a database of over 5,000 consecutive neurosurgical spine cases. Methods Surgical records were searched to identify all spine surgeries performed between January 2010 and July 2012. Anesthetized, nonoperative time was calculated from the anesthesia record and compared with both patient and procedure characteristics to determine any significant relationships Results There were 5,515 surgical cases with a mean age of 60.5 and mean body mass index (BMI) of 29.7; 3,226 (58%) were male subjects. There were 1,176 (21%) fusion cases, and level of pathology was predominantly lumbar (4,010 cases, 73%). Fusion cases had a significantly longer total anesthetized, nonoperative time (fusion: 98 minutes, nonfusion: 76 minutes, mean difference: 22 minutes, p < 0.0001). Significant factors affecting anesthetized, nonoperative time in nonfusion cases include age greater than 65 years (mean difference 5 minutes, p < 0.0001), American Society of Anesthesiologists (ASA) grade, and BMI (BMI < 25: 72 ± 1.2 minutes, BMI 25 to 29: 74 ± 0.6 minutes, BMI 30 to 39: 79 ± 0.6 minutes, BMI 40 + : 87 ± 1.8 minutes, p < 0.0001). Similarly, for fusion operations, age > 65 years significantly increased nonoperative time (mean difference 6 minutes, p < 0.01), as did increasing ASA (mean difference 9 minutes, p < 0.0001) and increasing BMI. Conclusion Patient and surgical factors, including ASA grade, BMI, level of pathology, and surgical approach, have noticeable effects on anesthetized, nonoperative times in spine surgery.
A functional variant in HOXA11-AS , a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer
Richards, Edward J., Permuth‐Wey, Jennifer, Li, Yajuan , Coppola, Domenico , Reid, Brett M. , Lin, Hui‐Yi , Teer, Jamie K. , Birrer, Michael J. , Lawrenson, Kate , Monteiro, Álvaro N.A. , Schildkraut, Joellen M. , Goode, Ellen L. , Gayther, Simon A. , Sellers, Thomas A. , Cheng, Jin Q. , Chen, Y. Ann , Berchuck, Andrew , Lawrenson, Kate , Monteiro, Alvaro N , Lin, Hui-Yi

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 33 | Pages: 34745-34757

10.18632/oncotarget.5784 | PMID 26430965 Get It

Transcriptome profiling reveals divergent expression shifts in brown and white adipose tissue from long-lived GHRKO mice
Zhi, Xu , Berryman, Darlene E. , Kopchick, John J. , Gesing, Adam , Fang, Yimin , Stout, Michael B, Stout, Michael B , Swindell, William R. , Rohde, Kyle H. , List, Edward Owen , Masternak, Michal M

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 29 | Pages: 26702-26715

10.18632/oncotarget.5760 | PMID 26436954 Get It

LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Huang, Ruea-Yea, Eppolito, Cheryl, Lele, Shashikant , Shrikant, Protul, Matsuzaki, Junko , Odunsi, Kunle , Huang, Ruea-Yea

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 29 | Pages: 27359-27377

10.18632/oncotarget.4751 | PMID 26318293 Get It

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells
Brusgard, Jessica L., Choe, Moran , Chumsri, Saranya , Renoud, Keli J., Sudol, Marius , Passaniti, Antonino , MacKerell, Alexander D.

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 29 | Pages: 28132-28150

10.18632/oncotarget.4654 | PMID 26320173 Get It

Practice Effects and Stability of Neuropsychological and UHDRS Tests Over Short Retest Intervals in Huntington Disease
Beglinger, Leigh J., Adams, William , Fiedorowicz, Jess G. , Duff, Kevin, Langbehn, Douglas R. , Biglan, Kevin , Caviness, John N., Olson, Blair, Paulsen, Jane S. , Caviness, John, Duff, Kevin, Fiedorowicz, Jess G

Journal of Huntington's Disease | September 29, 2015 | Volume: 4 | Issue: 3 | Pages: 251-260

10.3233/jhd-150159 | PMID 26444022 Get It

Abstract Background: In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by “practice effects” (PE) — performance improvement from prior exposure to test materials. Objective: A practice run-in (“dual baseline”) was used in an HD cognitive trial to determine if PE could be minimized and evaluate performance trajectories over multiple visits. Methods: Non-depressed adults ( N = 36) with mild to moderate HD-related cognitive deficits participated in a clinical trial to examine the efficacy of citalopram to enhance cognition. Cognitive tests were administered at three visits (2 weeks separating each visit), before active treatment randomization. Some tests were also administered at screening. Therefore 3–4 pre-treatment repetitions were available. We examined test improvement using repeated-measures ANOVAs with planned pairwise comparisons. Results: Despite the practice run-in and use of alternate test forms, results indicated ongoing improvements over at least three test sessions on all three UHDRS cognitive tests. Trails A and B showed improvements between the third and fourth session, which suggests that one pre-baseline visit may not be effective in reducing practice on this important and commonly used test. Conclusions: Overall, 7 out of 13 variables showed some degree of short-term PE, even after multiple sessions and alternate forms. Tests assessing processing speed and memory may be particularly confounded by ongoing PE across at least 2–3 sessions. Practice run-in periods and alternate forms may help minimize the impact of such effects in HD clinical trials but awareness of which tests are most susceptible to PE is important in clinical trial design.
Surrogate endpoints for clinical trials in primary sclerosing cholangitis: Review and results from an International PSC Study Group consensus process
Ponsioen, Cyriel Y. , Chapman, Roger W. , Chazouillères, Olivier , Hirschfield, Gideon M. , Karlsen, Tom H. , Lohse, Ansgar W. , Schrumpf, Erik, Trauner, Michael , Pinzani, Massimo , Gores, Gregory J. , Hirschfield, Gideon M

Hepatology | September 29, 2015 | Volume: 63 | Issue: 4 | Pages: 1357-1367

10.1002/hep.28256 | PMID 26418478 Get It

Primary sclerosing cholangitis (PSC) is a rare, but serious, cholestatic disease for which, to date, no effective therapy exists to halt disease progression toward end‐stage liver disease. Clinical trial design to study drugs that improve prognosis is hampered by the relatively low event rate of clinically relevant endpoints. To overcome this shortcoming, there is an urgent need to identify appropriate surrogate endpoints. At present, there are no established surrogate endpoints. This article provides a critical review and describes the results of a consensus process initiated by the International PSC Study Group to delineate appropriate candidate surrogate endpoints at present for clinical trials in this frequently dismal disease. The consensus process resulted in a shortlist of five candidates as surrogate endpoints for measuring disease progression: alkaline phosphatase (ALP); transient elastography (TE); histology; combination of ALP+histology; and bilirubin. Of these, histology, ALP, and TE came out as the most promising. However, the expert panel concluded that no biomarker currently exceeds level 3 validation. Combining multiple endpoints is advisable. Conclusion: At present, there are insufficient data to support level 2 validation for any surrogate endpoint in PSC. Concerted efforts by all stakeholders are highly needed. Novel, promising noninvasive biomarkers are under study and should be incorporated as exploratory endpoints in clinical trials. (Hepatology 2016;63:1357–1367)
Suicide by Shotgun in Southeastern Minnesota
Blessing, Melissa M. , Lin, Peter T.

Journal of Forensic Sciences | September 29, 2015 | Volume: 61 | Issue: S1 | Pages: No page available

10.1111/1556-4029.12946 | PMID 26418185 Get It

AbstractSuicide by shotgun is a common method of suicide with high regional variation. We sought to describe their distinct, challenging features and provide demographic and risk characteristics. We reviewed 228 gunshot wounds autopsied at Mayo Clinic from 1994 to 2014; of these, 75 (32.9%) were shotgun wounds. All were suicides and contact range. Ages ranged from 14 to 92 years old; of these, 97% were men. The majority involved the head (70.9%), were intraoral (48.2%), and had upward (73.2%) and backward (73.2%) directionality. Next most common was the chest (21.5%), with backward (94.1%) and downward (64.7%) directionality. Four involved multiple wounds. Wadding was recovered in 16 (21.3%) cases. Six (8.0%) had a survival period. Most (66.7%) took place at home. Seventy‐one percent had a known psychiatric history; 32.4% had positive toxicology. Although contact range shotgun wounds cause severe destruction, entrance wound and other characteristic are identifiable with thorough scene, autopsy, and radiographic documentation.
Arthroscopic Remplissage for Engaging Hill‐Sachs Lesions in Patients With Anterior Shoulder Instability
Dahm, Diane L., Krych, Aaron J. , Camp, Christopher L. , Krych, Aaron J

Arthroscopy Techniques | September 29, 2015 | Volume: 4 | Issue: 5 | Pages: No page available

10.1016/j.eats.2015.05.003 | PMID 26697311 Get It

Abstract Anterior shoulder instability is often accompanied by a Hill‐Sachs defect on the humeral head that can contribute to recurrent instability if not addressed at the time of surgery. We describe a method of performing arthroscopic remplissage to treat engaging Hill‐Sachs lesions in patients with glenohumeral instability. It has the benefits of being an efficient procedure that can be performed with minimal technical difficulty and can be used to augment other stabilization procedures such as labral repair. The indications for this technique include the presence of an engaging Hill‐Sachs defect in patients will little or no glenoid bone loss. In appropriately selected patients, arthroscopic remplissage has shown reduced rates of recurrent instability. Technique Video video See video under supplementary data.
Quo vadis: the re‐definition of “inborn metabolic diseases”
Rahman, Shamima , Baumgartner, Matthias R. , Patterson, Marc C. , Zschocke, Johannes , Patterson, Marc, Morava, Éva , Peters, Verena , Patterson, Marc , Baumgartner, Matthias

Journal of Inherited Metabolic Disease | September 29, 2015 | Volume: 38 | Issue: 6 | Pages: 1003-1006

10.1007/s10545-015-9893-x | PMID 26420281 Get It